论文部分内容阅读
目的对固尔苏(PS)应用于新生儿呼吸窘迫综合征的预防价值进行探讨。方法自2014年5月—2015年5月本院收治的患有呼吸窘迫综合征的102例新生儿患者为护理对象,依据出生时间平均分为PS治疗组和传统治疗组,每组各51例。2组患儿均给予相同的基础辅助治疗,PS治疗组在基础辅助治疗基础上使用PS治疗,经6 h的不同方案治疗对比分析2组患儿的动脉血气指标、常规生理指标及治疗后并发症发生率。结果与治疗前相比2组患儿的Apgar评分、血气指标、心率、呼吸频率均显著优于治疗前,差异有统计学意义(P<0.05);与传统治疗组相比,PS治疗组患儿Apgar评分、血气指标、心率、呼吸频率、并发症、用氧时间差异有统计学意义(P<0.05)。结论固尔苏在预防新生儿呼吸窘迫综合征(NRDS)中效果明显,在传统治疗的基础上进一步提高了新生儿出生后呼吸困难的治疗效果,降低了并发症的发生率保障了新生儿的健康。
Objective To explore the preventive value of Coulbuterol in the neonatal respiratory distress syndrome. Methods From May 2014 to May 2015, 102 neonates with respiratory distress syndrome admitted to our hospital were nurses. According to the average birth time, they were divided into PS treatment group and traditional treatment group, with 51 cases in each group . Two groups of children were given the same basic adjuvant therapy, PS treatment group on the basis of basic treatment with PS treatment, after 6 h of different programs to compare the two groups of children with arterial blood gas indicators, conventional physiological indicators and post-treatment complications The incidence of disease. Results Compared with those before treatment, Apgar score, blood gas index, heart rate and respiratory rate in two groups were significantly better than those before treatment (P <0.05). Compared with the conventional treatment group, the PS treatment group Apgar score, blood gas index, heart rate, respiratory rate, complications, oxygen time difference was statistically significant (P <0.05). Conclusion Guerfu Su in the prevention of neonatal respiratory distress syndrome (NRDS) effect is obvious, based on the traditional treatment to further improve the neonatal treatment of dyspnea after birth, reducing the incidence of complications to protect the newborn health.